
Michel Salzet
Axes de recherche
PRISM Inserm U1192
Prof. Michel Salzet is director of the Inserm U1192 PRISM laboratory
PRISM Inserm U1192 is belonging to the Health Technology Institute of French NIH (Inserm) and focused on both Technology Innovation and Therapeutic Innovation
Research Interests
My current researches are dedicated to onco-immunology through proteomics approaches. My first focus is the phenotyping switch of microglia/macrophages between pro-inflammatory and anti-inflammatory stages. The concept consists to force the switch back of macrophages associated tumor to anti-tumoral stages. I identified factors involved in this phenoswitch, among I identified proteins issued from non-coding regions of mRNA and Nc-RNA and I am currently working to develop a delivery process method based on engineered exosomes graft on magnetic microbeads and monitored by ultrasonic imaging. My second focus is SpiderMass project which consists in the development of a novel mass spectrometry-based technology for in vivo real-time mini invasive guided surgery.